Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma (ODYSSEY RCC)

NCT04919122 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT04919122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04919122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma (ODYSSEY RCC)
Lead sponsor
Duke University
Phase
Observational
Overall status
Active, not recruiting
Start date
April 1, 2022
Completion date
December 31, 2026
Enrollment
468 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic renal cell carcinoma